Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Johnson & Johnson $JNJ Shares Bought by Cerity Partners LLC
05:46am, Sunday, 07'th Dec 2025
Cerity Partners LLC lifted its position in shares of Johnson and Johnson (NYSE: JNJ) by 2.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commiss
Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression and treatment-free following a single infusion as early as second line Data suggest s
New data from Cohort 4 of the SunRISe-1 study show more than 95 percent of patients remained progression free at one year, with more than 92 percent not undergoing bladder removal Patients with this t
Beutel Goodman & Co Ltd. Reduces Stake in Johnson & Johnson $JNJ
05:56am, Friday, 05'th Dec 2025
Beutel Goodman and Co Ltd. lowered its holdings in Johnson and Johnson (NYSE: JNJ) by 5.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commissio
Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note
06:46pm, Thursday, 04'th Dec 2025
The latest trading day saw Johnson & Johnson (JNJ) settling at $202.48, representing a -1.39% change from its previous close.
The Dividend Stocks That Keep Paying Even When Markets Stumble
04:06pm, Thursday, 04'th Dec 2025
When it comes to weathering market volatility, there is no easy answer, and what's worse is that when investors, retail or otherwise, try to time the market, it usually ends in disaster.
3 Large Drug Stocks to Watch as the Industry Shows Some Recovery
10:31am, Thursday, 04'th Dec 2025
In the Large-Cap Pharmaceuticals industry, Lilly, J&J and Sanofi are worth retaining as the industry shows some recovery.
Edgestream Partners L.P. Sells 63,615 Shares of Johnson & Johnson $JNJ
04:38am, Thursday, 04'th Dec 2025
Edgestream Partners L.P. cut its stake in shares of Johnson and Johnson (NYSE: JNJ) by 70.7% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional inve
Johnson & Johnson (JNJ) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
02:13pm, Wednesday, 03'rd Dec 2025
Johnson & Johnson (JNJ) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now?
10:01am, Wednesday, 03'rd Dec 2025
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
3 Dividend Stocks Wall Street is Piling Into Before 2026
02:46pm, Tuesday, 02'nd Dec 2025
There is an apparent shift in how Wall Street views the stock market, as retail investors are increasingly doubting the AI rally.
JNJ Gets EU Nod for Imaavy in Generalized Myasthenia Gravis
11:10am, Tuesday, 02'nd Dec 2025
J&J gains EU approval for Imaavy, the first FcRn blocker for adults and adolescents with generalized myasthenia gravis.
Brandes Investment Partners LP Purchases 8,502 Shares of Johnson & Johnson $JNJ
04:36am, Tuesday, 02'nd Dec 2025
Brandes Investment Partners LP lifted its position in shares of Johnson and Johnson (NYSE: JNJ) by 2.1% in the second quarter, according to its most recent disclosure with the SEC. The institutional i
American Century Value Fund Q3 2025 Contributors/Detractors And Notable Trades
01:36pm, Monday, 01'st Dec 2025
Shares of Teradyne advanced sharply as investors cheered the company's robust earnings and outlook for Teradyne's artificial intelligence compute testing business. We initiated a position in this cust
Time to Shore Up Your Personal Portfolio With These 3 Bullet-Proof Blue-Chip Stocks
01:16pm, Monday, 01'st Dec 2025
There are a number of valid reasons why many investors may be souring on the ability of equity markets to continue to rise at a 20%+ rate in the years to come.
